NCT03565835View on ClinicalTrials.gov

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 13, 2018

Primary Completion Date

November 17, 2021

Study Completion Date

January 17, 2023

Conditions
Prostatic Neoplasms
Interventions
DRUG

Abiraterone Acetate

Abiraterone Acetate with Prednisone and with Discontinuation of GnRH Analogue

DRUG

Prednisone

Abiraterone Acetate with Prednisone and with Discontinuation of GnRH Analogue

Trial Locations (1)

10461

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03565835 - Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter